How government-dependent was TRAVERE THERAPEUTICS, INC. in fiscal year 2025?

In fiscal year 2025, US federal contract obligations equal at least 0.1% of TRAVERE THERAPEUTICS, INC.'s reported revenue - $334.9k in federal awards against $490.7M in revenue as filed with the SEC.

Cite as: FACTANKER, https://factanker.com/entity/9deff617-98ff-4c98-9348-f08fd314be50/government-dependency/2025

Fiscal year	Revenue (SEC, as filed)	Federal obligations	Share	Data status
FY 2025	$490.7M	$334.9k	≥ 0.1%	contracts only
FY 2024	$233.2M	$656.7k	≥ 0.3%	contracts only

Evidence
Revenue FY 2025: evidence fact bb4d4408… (SEC filing)
Federal obligations FY 2025: sum of 9 award records (USAspending bulk data)
Identity consolidation: CIK 0001438533 · UEI JUBZMHK84S36 - linked via evidence-backed same_as facts, see all facts of this organization

Methodology & sources
Revenue: company fiscal year, as filed with the SEC (XBRL concept per evidence fact). Obligations: US federal fiscal year of the award date, consolidated across all registrations of the corporate group. Computed in the database, precomputed weekly - never by a model. Sources: SEC EDGAR, USAspending (public domain).

Not claimed

The two periods do not align exactly: revenue follows the company's fiscal year, obligations the US federal fiscal year (Oct-Sep).
Years marked 'contracts only': grant/assistance awards are not yet loaded - the share is a floor, not the full figure.
Fiscal years without a share: obligations base files not yet loaded; a missing value means missing load, not zero government business.
Obligations are amounts obligated, not amounts paid out.
The share consolidates all registrations of the corporate group via evidence-backed identity links (same_as facts).

Latest fiscal year & all years · TRAVERE THERAPEUTICS, INC. - all facts · Use this metric in your own models: JSON/API · API/MCP quickstart